Madrigal Pharmaceuticals Inc（MDGL）价格预测MDGLMadrigal Pharmaceuticals Inc

Alphio's MDGL stock price prediction model matches the current Madrigal Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $437.24 (+0.69%). The 1-week path is $445.62 (+2.62%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Madrigal Pharmaceuticals is a good buy right now due to its strong sales growth momentum, with Rezdiffra achieving $364.3 million in Q2, a 71% year-over-year increase. Additionally, the stock is currently priced at $434.24, significantly below analyst price targets ranging from $605 to $964, indicating potential upside. However, the current RSI of 24.769 suggests the stock is oversold, which could present a buying opportunity. The main risk is the forward P/E ratio of 78.125, indicating high expectations for future earnings that may not materialize.

Madrigal Pharmaceuticals Inc (MDGL) last closed at $434.24, losing -4.21%. These facts feed the 1-day and 1-week MDGL price prediction above.